Find the latest available information and answers to frequently asked questions about #COVID19 on our website: fda.gov/emergency-prep…

Attending the ABA Litigation Section virtual SAC General Counsel Forum. Such a great way to hear from experienced GC on addressing the challenges they’re facing today. Snell & Wilmer

The state-funded Advanced Industries Accelerator Grant Program remains at risk. Due to a delayed vote, there’s still time to take action. Please join our advocacy efforts and email now: action.bio.org/RYNz6zq #cobioscience #strongertogether

Thank you Congressman Perlmutter for meeting with ⁦Colorado BioScience Association⁩ ⁦and I appreciated the opportunity to kick off the presentation today. ⁦Ed Perlmutter⁩ ⁦Snell & Wilmer⁩

Honored to be a part of the Colorado BioScience Association Board of Directors and work to advance the industry sector in Colorado Snell & Wilmer

Snell & Wilmer Partner Rose B. Sorensen was selected for Los Angeles Business Journal’s Leads of Influence: Private Equity Investors and Advisors list. swlaw.com/assets/pdf/new… #privateequity

Honored to be recognized in The Best Lawyers in America 2021 with my wonderful S&W colleagues. I am grateful to have been nominated and selected by my peers for this great achievement. #BestLawyers

Thank you Senator Bennet for speaking today with our leaders of the Colorado bioscience community. ⁦Snell & Wilmer⁩ ⁦Colorado BioScience Association⁩ ⁦ABA Litigation Section⁩

This week on CalCurrent, guest host, Daniel S. Wittenberg highlights the recent developments and nuances stemming from the Operation Warp Speed declaration. Listen to Episode 29: Tort Litigation Immunity for COVID-19 Vaccines. #COVID19 lnkd.in/des6sME

Today, we are sharing the FDA’s Food Safety and Nutrition Survey. This is a nationally representative survey of consumers’ self-reported behaviors, knowledge, attitudes, and beliefs around food safety and health and diet issues. go.usa.gov/xsfHW

Fantastic meeting with Congressman Joe Neguse today to discuss issues important to the Colorado life science and MedTech industry sector. Thank you for all you are doing and your leadership in Congress. #cobioscience #swlawnews

Deadline Today: Colorado state legislature is considering Senate Bill 175 that threatens life sciences innovation. CBSA is asking legislators to remove the review board’s authority to set upper payment limits. Take Action: lnkd.in/gSaK9aS #StrongerTogether #CoBioScience

Snell & Wilmer is pleased to announce that Barbara J. Dawson, a partner with more than three decades of service at the firm, has assumed the firm’s chair, effective April 12. Dawson takes over for Matthew P. Feeney. bit.ly/411vnxx

And we’re off and running at the CBSA medical device symposium. First speaker is Antoinette Gawin, Pres & CEO of Terumo BCT. Thank you Antoinette and TBCT for your contribution to the Colorado Medtech ecosystem.

Snell & Wilmer is pleased to announce that 39 attorneys in the Phoenix and Tucson offices have been selected for inclusion in the 2023 Southwest Super Lawyers publication. Of those 39, 15 were recognized as Southwest Rising Stars. #attorneys #lawfirm bit.ly/41tybTJ

Our CEO Antoinette Gawin gave the keynote at Colorado BioScience Association's Annual Medical Device Symposium. Antoinette shared: “Leadership is #innovation. You can’t lead without innovation. You can’t innovate without #leadership.” #medtech #Colorado

CBSA’s Medical Device Symposium makes headlines: Elise Reuter from MedTech Dive, a national publication focused on medical device innovation, highlighted trends discussed during the Intersections in Medical Device Innovation Panel. Learn more: medtechdive.com/news/medtronic…

"If you can’t bring your full self to the workplace, we won’t get the best out of you." Our President and CEO Antoinette Gawin appeared on Voices of Biotech, speaking about topics including vulnerability in the workplace. ➡️ Episode: bit.ly/426NKRP

linkedin.com/posts/danwitte…

#NewProfilePic